RxDoctor Payments Data

Anmol Clairmont, PA

Physician Assistant · Minneapolis, MNNPI 1255970489

Payments from drug & device makers

$3,135in general payments, 2019–2025

Across 128 payments — averaging $24.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scilex Pharmaceuticals Inc.$569
  • Medtronic$354
  • Forte Bio-pharma LLC$239
  • Axsome Therapeutics, Inc.$228
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$201
  • Jazz Pharmaceuticals Inc.$197
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$3,135100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,135 in reported general payments places this provider in the 95th percentile of 3,121 physician assistant providers in Minnesota.

See all physician assistant providers in Minnesota

Medicare billing

Part B allowed, 2024
$35,534
Medicare patients
64
Services billed
547

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate36$66,260
RelistorMethylnaltrexone Bromide16$54,242
Xtampza ErOxycodone Myristate113$34,689
ZtlidoLidocaine22$26,975
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen448$26,315
Aimovig AutoinjectorErenumab-Aooe23$22,573
Nucynta ErTapentadol Hcl22$13,372
Ajovy SyringeFremanezumab-Vfrm18$13,122
BelbucaBuprenorphine Hcl16$11,974
Hysingla ErHydrocodone Bitartrate27$11,884
Lidocaine82$9,981
MovantikNaloxegol Oxalate18$8,320
LinzessLinaclotide15$8,137
Buprenorphine25$8,013
Diclofenac Sodium36$6,602

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$29$66,26036 claims
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er, Belbuca$130$60,036151 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$201$54,24216 claims
Scilex Pharmaceuticals Inc.Ztlido$569$26,97522 claims
AbbVieLinzess$97$8,13715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,121 physician assistant providers in Minnesota.

Other physician assistant in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →